Based on a few early studies indicating a relative sparing of GABA levels and GAD activity in the AD brain [174,205,212,217], it has long been believed that GABAergic neurons are relatively spared during the pathogenesis of the disease. This evidence concerns the gene GAD1 and Alzheimer disease.